SCHEMBL8307725

SCHEMBL8307725

O=C(O)C(F)(F)C(O)c1ccncc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 1/20 0.40
NAPRT Q6XQN6 1/20 0.39
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PLOD2 O00469 1/20 0.37
PLOD3 O60568 1/20 0.37
PLOD1 Q02809 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
HDAC3 O15379 1/20 0.36
CYP2C9 P11712 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15114536 0.82 LMNA (0.47) CES2CES1GABBR2GABBR1L3MBTL1
SCHEMBL8448238 0.79 KDM4E (0.42) KDM4EHSD17B10PLOD2PLOD3PLOD1
SCHEMBL24361176 0.78 ESR1 (0.48) KDM4EHSD17B10CES2CES1CYP2C9
SCHEMBL24361184 0.78 HDAC3 (0.41) CES2CES1HDAC3HDAC4HDAC1
SCHEMBL2334995 0.77 CYP3A4 (0.41) KDM4EHSD17B10SLC6A2SLC6A4SLC6A3
SCHEMBL32691841 0.77 KDM4E (0.40) KDM4EHSD17B10NAPRTSLC6A2SLC6A4
SCHEMBL23559271 0.77 TPMT (0.39) CES2CES1CYP2C9HDAC1HDAC7
SCHEMBL8305982 0.75 NAMPT (0.40) KDM4EKMT2ACYP3A4CYP19A1
SCHEMBL24360844 0.72 GABBR2 (0.44) HSD17B10MEN1KMT2ACYP3A4GABBR2
SCHEMBL19510381 0.70 L3MBTL1 (0.41) HSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0583421-B1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE SEARLE & CO (US) 1999-06-16 EP disclosed
EP-0512400-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use SEARLE & CO (US) 1998-12-02 EP disclosed
US-5576315-A Substituted dibenzoxazepine compounds and methods for treating osteoporosis and ischemia G.D. SEARLE & CO. (US) 1996-11-19 US disclosed
US-5464830-A ANALGESICS G. D. SEARLE & CO. (US) 1995-11-07 US disclosed
US-5378840-A Substituted dibenzoxazepine compounds G. D. SEARLE & CO. (US) 1995-01-03 US disclosed
EP-0583421-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1994-02-23 EP disclosed
WO-1992019617-A2 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1992-11-12 WO disclosed
EP-0512400-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 EP disclosed